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In the United Kingdom, human immunodeﬁciency virus (HIV) transmission amongmenwho have sex withmen
(MSM) is not under control, despite readily available treatment, highlighting the need to design a cost-effective
combination prevention package. MSM report signiﬁcantly reduced transmission risk behavior following HIV
diagnosis. To assess the effectiveness of HIV diagnosis in averting transmission during highly infectious pri-
mary HIV infection (PHI), we developed a stochastic individual-based model to calculate the number of HIV-
transmission events expected to occur from a cohort of recently infectedMSMwith and those without the behavior
changes reported after diagnosis. The model incorporates different types of sex acts, incorporates condom use,
and distinguishes between regular and casual sex partners. The impact on transmission in the 3 months after
infection depends on PHI duration and testing frequency. If PHI lasts for 3 months and testing is performed
monthly, then behavior changes after diagnosis would have reduced estimated transmission events by 49%–52%,
from 31–45 to 15–23 events; a shorter duration of PHI and/or a lower testing frequency reduces the number of
infections averted. Diagnosing HIV during PHI can markedly reduce transmission by changing transmission-
risk behavior. Because of the high infectivity but short duration of PHI, even short-term behavior change can
signiﬁcantly reduce transmission. Our quantiﬁcation of the number of infections averted is an essential com-
ponent of assessment of the cost-effectiveness of strategies to increase detection and diagnoses of PHI.
Keywords. men who have sex with men; primary HIV infection; diagnosis; counseling; behavior change;
HIV transmission risk; infections averted; mathematical model.
In the United Kingdom, transmission of human immu-
nodeﬁciency virus (HIV) among men who have sex with
men (MSM) has continued to remain high, despite the
ready availability of treatment [1–3].Despite the high ef-
ﬁcacy of treatment as prevention (TasP) [4], Brown et al
[5] report that TasP will have little impact in the United
Kingdom, where treatment is readily available to
those with diagnosed HIV infection and there is relatively
little transmission from those with diagnosed infection
who are not receiving treatment. There is a need for
more-widespread and more-frequent testing to identify
undiagnosed infections [3, 5] and for more-effective
interventions [3] as part of a combination of measures.
Primary HIV infection (PHI) is highly infectious (be-
cause of the associated high viral load) and is often
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associated with high-risk sexual behavior [6].However, it is also
transient, and its importance in HIV transmission is debated
and depends upon context [7]. A recent modeling study esti-
mated that 48% of HIV infections acquired by MSM in the
United Kingdom arose from undiagnosed PHI [3], which is
in line with phylogenetic studies [8, 9]. Therefore, diagnosing
HIV infection in high-risk individuals during PHI may be high-
ly effective if it facilitates effective reduction of the transmission
risk. However, diagnosing HIV infection during PHI requires
frequent testing, which is likely to be expensive and difﬁcult
to achieve, so it is important to quantify the beneﬁts of in-
creased efforts to diagnose PHI infection.
We previously reported that most high-risk MSM in whom
HIV infection was recently diagnosed and who underwent stan-
dard safer-sex counseling during care changed their sexual be-
havior [10]. In general, they reported an increased frequency of
condom use and fewer sex partners, thereby reducing their risk
of transmission, for at least the 3-month follow-up period stud-
ied [10]. To assess the effectiveness of early diagnosis of HIV
infection in high-risk MSM to prevent HIV transmission, we
developed a stochastic, individual-based mathematical model
to quantify the number of HIV transmission events expected
to be averted by the postdiagnosis behavior change, accounting
for increased infectivity during PHI and uncertainty in param-
eter estimates, including the duration of PHI.
METHODS
A mathematical model, described below, was developed to
analyze the results of the study in London, United Kingdom,
by Fox et al [10], who interviewed MSM with recently acquired
HIV infection about their sexual behavior in the 3-month peri-
ods before and after HIV diagnosis, using a standardized ques-
tionnaire. At baseline (median, 7 days after diagnosis) and
3-month follow-up, participants reported their number of sex
partners (regular and casual) in the previous 3 months, the fre-
quency of types of sex acts (insertive anal, receptive anal, inser-
tive oral and receptive oral), and the frequency of condom use
(always, sometimes, or never) for each type of sex act with each
type of partner, and the HIV status of their regular partner (pos-
itive, negative, unknown, or not applicable); the HIV status of
casual partners was not reported [10]. Ninety-eight of 104 eligi-
ble MSM were enrolled, and there was 100% follow-up. Partic-
ipants were offered antiretroviral therapy (ART) at diagnosis,
which 73 accepted; there was no difference in the behavior
change in those who did or did not accept ART (χ2 = 0.224;
P = .636). In this analysis we are interested in the effects of be-
havior change and do not consider the effects of ART on trans-
mission from those who received it. Most participants (96%)
were white; the median age was 33 years (range, 20–59 years).
At baseline, 52 reported a regular partner, with 10 reporting
that they were monogamous. Of the 52 regular partners, 24
were HIV negative and 18 were HIV positive at the time of di-
agnosis of the index case, and 10 had an unknown HIV status.
The numbers of casual sex partners and changes after diagnosis
are illustrated in Figure 1.
A stochastic, individual-based Monte Carlo simulation was
developed to calculate the number of transmission events that
would have occurred from each study participant during the
3-month period after infection under the following scenarios:
(1) HIV infection had not been diagnosed, and therefore the
prediagnosis behavior pattern had occurred throughout the 3
months; (2) HIV infection was diagnosed immediately, so
that the postdiagnosis behavior pattern had occurred through-
out the 3 months; and (3) since immediate diagnosis of HIV
will be rare, the effects of different testing frequencies, ranging
from twice per month to once every 2 months, was also exam-
ined, so the proportion of PHI during which the postdiagnosis
behavior change occurs varies.
For each scenario examined, 10 000 model realizations were
performed.
In each model realization, the number of partners of each
respondent who became infected was determined randomly,
by ﬁrst determining randomly how many of the partners were
HIV negative (and therefore at risk of becoming infected) and
then determining randomly which of those partners became
infected, based on the probability of transmission, which was
calculated using a Bernoulli-process model. This was based
on the risk score model of Fox et al [11], with the important
difference that the risk score calculates the risk of an HIV-
negative individual acquiring HIV, which can only happen
once, whereas our model calculates the expected number of
HIV transmission events from an HIV-positive individual.
Figure 1. Reported numbers of casual sex partners in the 3-month pe-
riods before and after diagnosis of human immunodeﬁciency virus infec-
tion. The symbol (+) represents an increase in the number of casual
partners after diagnosis, the symbol (−) represents a decrease, and the
absence of a symbol represents no change. Most respondents greatly
reduced their numbers of casual partners, with many reporting none,
although a few reported increased numbers. Data are from Fox et al [9].
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where i is the sex-act type (insertive anal, receptive anal, or in-
sertive oral), j is the partner type (regular or casual), βi is the
transmission probability per sex act of type i, w is the factor in-
creasing infectivity due to PHI (which takes the value 1 when
PHI has ended), σi is the proportionate reduction in βi due to
condom use, πj is the proportion of partners of type j who are
already infected with HIV (ie, prevalence), NCi,j is the number of
sex acts of type i with a partner of type j in which a condom was
used, NNi,j is the number of sex acts of type i with a partner of
type j in which a condom was not used, and Nj is the number
of partners of type j.
In the model, sex acts of each type were distributed over the
partners, because Fox et al [10] asked respondents to specify the
frequency of sex acts of each type and the number of partners,
rather than to provide a detailed report about their sexual be-
havior with each individual partner. Because the HIV status
of casual partners was not known, it was determined randomly,
with the probability of each partner being HIV positive equal to
the prevalence of HIV infection among high-risk MSM in Lon-
don (12.3%; 95% conﬁdence interval [CI], 10.7%–14.1%) [12].
When the HIV status of the regular partner was unknown, it
was determined randomly with the probability that the regular
partner was HIV positive being the equal to the proportion of
regular partners of known HIV status who were HIV-positive
(ie, 18 of 42 [43%; 95% CI, 28%–59%]) [10]. If condom use
was described as “sometimes,” then condoms were assumed
to have been used on 50% of occasions. Condoms were assumed
to reduce the per-act transmission probability by 80% (95% CI,
53%–92%) [13].
Transmission probabilities per act for each type of act were
taken from literature. For anal sex, 2 recent articles reported dif-
ferent estimates: Scott et al [14] estimated transmission proba-
bilities of 0.73% (95% CI, .45%–.98%) and 0.22% (95% CI,
.05%–.39%) when the HIV-positive partner is insertive and re-
ceptive, respectively. Corresponding estimates from Patel et al
[15] were 1.38% (95% CI, 1.02%–1.86%) and 0.11% (95% CI,
.04%–.28%). Note that these are probabilities of transmission
from the HIV-positive person, who were the respondents in
Fox et al’s behavioral survey, not probabilities of acquisition by
the HIV-negative person, so the probabilities are higher where
the respondent is the insertive partner. We compared scenarios
using the estimates from Scott et al to scenarios using the esti-
mates from Patel et al for anal sex (the estimates from Vittinghoff
et al [16] were intermediate, relative to those from Scott et al and
Patel et al). In all cases, the transmission probability used for in-
sertive oral sex was 0.04% (95% CI, .01%–.17%) [16]; receptive
oral was assumed to have negligible risk.
Because the duration of PHI is uncertain, we varied the as-
sumed value, using 1.25 months (Hollingsworth et al [17] esti-
mated a lower bound of 1.23 months), 2 months, 2.5 months
(the duration used by Wawer et al [18]), and 3 months (the
duration for which we have behavioral data), which is the
commonly assumed duration [6]. The estimated increase in
infectivity of 7.25 (95% CI, 3.05–17.3) [15, 18] is based on an
assumed 2.5-month duration of PHI; in the scenarios where
the duration of PHI was varied, the infectivity multiplier was
adjusted inversely: for example, if PHI lasts 3 months, then it
is adjusted by a factor of 2.5/3 = 0.833, whereas if PHI lasts
1.25 months, then it is adjusted by a factor of 2.5/1.25 = 2.
RESULTS
In the baseline scenario, in which we examined what would
have happened if the modeled MSM had not received a diagno-
sis of HIV infection and their pattern of behavior reported in
the prediagnosis period had continued unchanged throughout
the 3 months after infection, then the predicted number of HIV
transmission events occurring from the cohort of 98 MSM
would have been 31 (95% CI, 14–55) and 33 (95% CI, 17–
56), using the parameter values from Scott et al and assuming
PHI lasts 3 months or 1.25 months, respectively; corresponding
estimates using the values from Patel et al were 45 (95% CI, 22–
80) and 48 (95% CI, 25–82), respectively. In the scenario in
which all of the modeled MSM received a diagnosis of HIV in-
fection immediately and their postdiagnosis behavior pattern
had occurred throughout the 3 months after infection, there
would have been a reduction of 65% (using the estimates
from Scott et al) or 64% (using the estimates from Patel et al)
in the number of transmission events (Figure 2), compared with
the respective baseline scenarios. Since immediate diagnosis
could not be practicably achieved, we examined the effect of
testing twice per month, once per month, twice every 3 months,
and once every 2 months (Figure 2). An important cause of un-
certainty in the numbers of infections averted is uncertainty in
the transmission probabilities associated with anal sex, with the
estimates of Patel et al leading to a greater number of infections
occurring and therefore a greater number averted by postdiag-
nosis behavior change. As the frequency of testing declines, so
does the number of infections averted. If PHI lasts for 3 months,
then testing every month could avert a substantial number of
S596 • JID 2014:210 (Suppl 2) • White et al
infections. Importantly, if the duration of PHI is as short as 1.25
months, then it is necessary to have very frequent testing—twice
per month—to avert a substantial number of infections; other-
wise, infection will be undiagnosed for the majority of the period
of PHI. Note that our analysis considers the 3-month period after
HIV infection, and therefore if diagnosis occurs toward the end of
this period then there is little impact in terms of calculated num-
bers of infections averted; however, the actual number of infec-
tions averted would be greater than this because the behavior
change associated with the 3-month period after diagnosis [10]
would extend beyond the period considered in our analysis.
Importantly, these calculations account for the heterogeneity
in the reported behavior change [10]: 74 of 98 MSM in whom
HIV was recently diagnosed (76%) changed their behavior to
greatly reduce the risk of transmission to others in the 3 months
following their HIV diagnosis. Therefore, the postdiagnosis
transmission risk in the cohort was concentrated in approxi-
mately a quarter of individuals, some of whom increased their
numbers of casual partners. However, it is important to note
that we do not know whether they were serosorting to reduce
their transmission risk or using condoms selectively with
partners known to be HIV negative or of unknown status.
Therefore, it is possible that we may have overestimated the
transmission risk from these individuals.
DISCUSSION
The incidence of HIV infection among MSM in the United
Kingdom has remained high despite the ready availability of
ART [1–3], and further intervention efforts are required [3,
5]. Earlier diagnosis of HIV through more-frequent testing is
required as part of a package of interventions [5]. However,
with limited resources, interventions need to be cost-effective.
In this analysis, we assess the effectiveness, in terms of numbers
of transmission events averted, of diagnosis of HIV infection in
the ﬁrst 3 months of infection, considering the effect of HIV
diagnosis on sexual risk behavior.
Fox et al [10] found that MSM with a recent diagnosis of HIV
infection substantially changed their sexual behavior, thereby
reducing the risk of onward transmission. The modeling
Figure 2. Numbers of infections averted in the 3 months following human immunodeﬁciency virus (HIV) infection under different scenarios. The graph
shows the median, interquartile range, and 95% range of the estimated number of infections averted with different frequencies of testing, using trans-
mission probabilities for anal sex estimated by Patel et al [15] (A) and Scott et al [14] (B). Numerical labels on the horizontal axis indicate the assumed
duration of primary HIV infection (PHI) in months. As the frequency of testing declines, so does the number of infections averted. If the duration of PHI is as
short as 1.25 months, then very frequent testing—twice every month—is necessary to avert a substantial number of infections.
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analysis in this article indicates that a signiﬁcant number of HIV
transmission events would be averted by this behavior change if
it were to occur during PHI, provided that testing were sufﬁ-
ciently-frequent to detect PHI, which of course depends on
the duration of PHI. This quantiﬁcation of the outcome of
interest—the number of infections averted—is an essential
component in assessing the cost-effectiveness of interventions
where the study end point was behavior change, rather than
measured incidence of infection.
Our ﬁndings indicate that a policy of frequent testing of those
at high risk of HIV infection, to ensure that the decrease in risk
behavior, even if only for a limited interval around their most in-
fectious period, has the potential to avert a signiﬁcant number of
infections at the population level, provided that the duration of
PHI is not too short for testing at the necessary frequency to
be feasible. However, assessment of the cost-effectiveness of an
intervention is complex and context speciﬁc—it requires consid-
eration of multiple contextual factors, including targeting and
conﬁguration of services, the associated costs and uptake of test-
ing by relevant client groups (which determines the average num-
ber of tests needed to identify a case of PHI), and the cost-savings
and quality-of-life gains that accrue from averting infections—
and is therefore beyond the scope of this article. However,
more-frequent testing in genitorurinary medicine and HIV ser-
vices is only one approach to increasing diagnoses of PHI, and
enhanced recognition of the symptoms of seroconversion in
other healthcare settings contributes to the new proposed self-
testing initiatives [19]. Alternatively, rather than routine frequent
testing, it might be more cost-effective to encourage testing soon
after episodes of high-risk behavior, provided there is clear, well-
understood guidance on a what constitutes such behavior.
With around half of new HIV infections arising from individ-
uals with PHI [3, 8], rapid contact tracing involving individuals
who recently received a diagnosis of HIV infection could be an
effectiveway to identify PHI cases: even if the initial primary case
has progressed from the PHI stage, cosecondary cases might be
identiﬁed while still in PHI. However, most of the transmission
risk reported by the MSM studied by Fox et al [10] involves
casual partners, for whom partner notiﬁcation might not be
possible.
Although a signiﬁcant number of transmission events were
calculated to be averted by the behavior change associated
with HIV diagnosis and entry into standard care, transmission
risk remains, and there is scope for further improvement. ART
is likely to be beneﬁcial in reducing transmission from PHI by
reducing viral load, and, encouragingly, Fox et al [10] found that
choosing ART was not associated with behavioral disinhibition.
However, the time taken for viral load to be suppressed [20]will
limit ART’s impact on transmission from individuals during
PHI, and therefore behavior change during this period is
vital. As behavior-change interventions are costly and their
effects typically transient [21, 22], resources need to be focused
where they will be most effective. Fortunately, diagnosis of HIV
infection coupled with standard safer-sex counseling was sufﬁ-
cient for three quarters of individuals to eliminate their risk of
onward transmission for at least the same length of time as the
duration of PHI—they did not require intensive behavior-
change interventions [10]. This means that intervention efforts
could be targeted at the remaining quarter of patients who did
not eliminate their transmission risk, with a small proportion
having increased their risk (although we do not know the extent
to which it was mitigated by serosorting and/or increased con-
dom use, which were not evaluated in that study).
Strengths of the study upon which this analysis is based are
the high participation rate (98 of 104 MSM), the 100% follow-
up rate, and the fact that the intervention was standard treat-
ment and counseling and, therefore, was representative of
what occurs in practice [10]. However, for casual partners we
do not know how numbers of each type of sex act and patterns
of condom use were distributed; having this information would
have increased the precision of our analysis. Additionally, there
are a number of limitations of our analysis, which will result in
an underestimation of the beneﬁts of early HIV diagnosis in
averting transmission. First, this analysis only considers averted
transmission from the index cases and does not consider the ad-
ditional infections that would otherwise have occurred from the
secondary cases that were averted. The longer-term population-
level impact of rapid diagnosis of HIV infection depends on
factors that include the phase of the epidemic, coverage of the
testing, and the presence of other interventions. Second, after
HIV diagnosis, reductions in transmission-risk behavior may
persist in the longer term beyond the period studied by Fox
et al [10]. Third, early HIV diagnosis provides entry into care,
facilitating provision of ART and reducing the infectivity of the
individual through reductions in viral load. Finally, serosorting
behavior—speciﬁcally choosing partners known to be HIV pos-
itive, for unprotected anal intercourse, to eliminate the risk of
transmission to them [23–25]—was not investigated by the
empirical study [10], so we do not know the extent to which
it occurred, although its occurrence was likely [26]. Serosorting
could have signiﬁcantly further reduced the number of trans-
mission events below the calculations of this article: if casual
partners were selected to be HIV positive, then the risk of trans-
mission from study respondents would have been eliminated.
(Of course, serosorting is only protective if the serostatus is
known accurately; otherwise, the transmission risk is increased
[27]). It is possible that inconsistent condom use with casual
partners represents consistent condom use with partners who
are known to be HIV negative or have an unknown HIV infec-
tion status and no condom use with partners known to be HIV
positive. Therefore, it would be beneﬁcial if future empirical
studies assessed, in more detail, patterns of condom use and
serosorting behavior, and assessed behavior over the longer
term.
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Nevertheless, targeting prevention efforts at high-risk indi-
viduals during the period of PHI, so that the marked behavior
change associated with recent diagnosis of HIV infection coin-
cides with the period of peak infectivity, possibly supplemented
by ART, could be an efﬁcient use of limited HIV-prevention
resources.
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